Streetbeat News

Products Services

LYV

The UK government is examining dynamic pricing practices by ticketing websites after Oasis fans faced high ticket prices for the band's reunion tour. Ticketmaster, owned by Live Nation Entertainment Inc (NYSE:LYV), is under scrutiny for its pricing strategies, which have led to complaints and government intervention.

Portfolio Pulse from Franca Quarneti

September 03, 2024 | 9:33 pm

AMZN

BA

LMT

RKLB

The space race between Jeff Bezos and Elon Musk intensifies as Amazon's Project Kuiper secures licenses in New Zealand, potentially collaborating with Rocket Lab. This move challenges Musk's Starlink, which has a significant head start. Bezos is also focusing more on Blue Origin, signaling a deeper rivalry with Musk's SpaceX.

Portfolio Pulse from Chris Katje

September 03, 2024 | 9:19 pm

CLOV

Clover Health's stock surged over 21% in after-hours trading following a multi-year agreement between its subsidiary, Counterpart Health, and The Iowa Clinic. The deal involves providing a cloud-based software platform to clinicians, with potential incentive payments tied to care management goals.

Portfolio Pulse from Adam Eckert

September 03, 2024 | 9:17 pm

PFE

Acepodia has entered a strategic clinical collaboration with Pfizer Ignite to develop its therapies for autoimmune diseases. Pfizer Ignite will provide strategic guidance and resources, enhancing Acepodia's drug development process.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 9:04 pm

PM

Deep-pocketed investors are showing a bullish trend in Philip Morris Intl (NYSE:PM) options trading, with 18 significant options activities noted. The sentiment is mixed, with 55% bullish and 27% bearish. The stock is currently trading at $125.71, up 1.96%, and is considered overbought. Barclays maintains an Overweight rating with a $130 target.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 8:45 pm

CLOV

Clover Health Investments' shares rose following a multi-year agreement between its subsidiary, Iowa Clinic, and Counterpart Health to implement AI technology across Midwest providers.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:43 pm

AAPL

AAPU

AAPX

FTEC

IYW

VGT

Gene Munster predicts that Apple's iPhone 16 launch will initially disappoint investors, but the stock is expected to rise significantly after the company's third-quarter earnings report due to anticipated AI features. Apple shares fell 2.72% recently, and ETFs holding Apple also declined.

Portfolio Pulse from Michael Juliano

September 03, 2024 | 8:37 pm

ATHA

Athira Pharma's shares dropped after the company's Phase 2/3 LIFT-AD trial for Fosgonimeton in Alzheimer's disease failed to meet primary and key secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:32 pm

CLLS

Cellectis has presented pre-clinical evidence showing that their TALEN-edited MUC1 CAR T-cells can effectively reduce triple-negative breast cancer while maintaining safety. This development is significant for the company's research and potential future treatments.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:31 pm

CW

Curtiss-Wright has secured a $26 million multi-year contract with the Belgian Air Force to modernize its aircraft arresting systems, supporting the delivery of the F-35 and enhancing military flight operations.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:31 pm